Skip to content

ClearPoint Neuro CLPT Interest coverage

Interest coverage at other companies

Abbott logo
AbbottABT
14.4×+1.4×
Boston Scientific logo
Boston ScientificBSX
10.6×+1.7×
IAR
Integra LifeSciencesIART
-5.4×-5.6×
Medtronic logo
MedtronicMDT
9.1×+0.9×
Neuropace, Inc. logo
Neuropace, Inc.NPCE
-2.5×+0.3×
AngioDynamics logo
AngioDynamicsANGO
-1,017×

Other financials

Income statement

See full
Revenue$12.1M+42.9%
Gross profit$7.8M+51.1%
Operating income-$8.5M-37.6%
Net income-$9.6M-58.5%
EPS (diluted)-$0.32-45.5%

Balance sheet

See full
Cash & equivalents$36.5M+195%
Total debt$63.6M+1,750%
Total equity$18.8M-5.7%
Total assets$93.4M+211%

Cash flow

See full
Operating cash flow-$8.0M-29.1%
CapEx$645.0K+252%
Free cash flow-$8.6M-35.5%

Valuation

See full
Market cap$538.61M+69.2%
Enterprise value$565.68M+82.9%
P/S13.3×+3.4×

Profitability

See full
Gross margin62.3%+1.1pp
Operating margin-65.2%-1.9pp
Net margin-71.6%+8.8pp
FCF margin-65.7%+269pp

Returns & leverage

See full
Return on equity-149.7%+4,074pp
Debt / equity3.4×+3.2×
Current ratio5.8×+2.3×

Where this comes from

Calculated from ClearPoint Neuro’s reported figures.

Based on trailing twelve months.

The official record: ClearPoint Neuro’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about ClearPoint Neuro's interest coverage.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is ClearPoint Neuro's interest coverage?
ClearPoint Neuro (CLPT) reported interest coverage of -55.8× in Q1 2025.
What is the long-term trend for ClearPoint Neuro's interest coverage?
Over 2 years (2020 to 2024), ClearPoint Neuro's interest coverage has grown at a 197.4% compound annual growth rate (CAGR), from -4.3× to -38.1×.
What does interest coverage mean?
Trailing-twelve-month operating income (EBIT) divided by interest expense. Measures how many times over the company can cover its interest payments from operating profit.